These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 33307962)

  • 1. HMGA2 promotes breast cancer metastasis by modulating Hippo-YAP signaling pathway.
    Xu J; Fang X; Long L; Wang S; Qian S; Lyu J
    Cancer Biol Ther; 2021 Jan; 22(1):5-11. PubMed ID: 33307962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ZNF213 negatively controls triple negative breast cancer progression via Hippo/YAP signaling.
    Liu Y; Su P; Zhao W; Li X; Yang X; Fan J; Yang H; Yan C; Mao L; Ding Y; Zhu J; Niu Z; Zhuang T
    Cancer Sci; 2021 Jul; 112(7):2714-2727. PubMed ID: 33939216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy promotes triple negative breast cancer metastasis via YAP nuclear localization.
    Chen W; Bai Y; Patel C; Geng F
    Biochem Biophys Res Commun; 2019 Dec; 520(2):263-268. PubMed ID: 31590917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hydnocarpin inhibits malignant progression of triple negative breast cancer via CNOT4-mediated ubiquitination and degradation of YAP].
    Ou HL; Wu H; Ren YL; Si Y; Duan ZQ; Liu XW
    Zhongguo Zhong Yao Za Zhi; 2023 Aug; 48(16):4483-4492. PubMed ID: 37802875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulating HMGA2 attenuates epithelial-mesenchymal transition-induced invasion and migration in nasopharyngeal cancer cells.
    Xia YY; Yin L; Jiang N; Guo WJ; Tian H; Jiang XS; Wu J; Chen M; Wu JZ; He X
    Biochem Biophys Res Commun; 2015 Jul; 463(3):357-63. PubMed ID: 26025649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway.
    Zhao XP; Zhang H; Jiao JY; Tang DX; Wu YL; Pan CB
    J Transl Med; 2016 Jan; 14():26. PubMed ID: 26818837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Luteolin suppresses epithelial-mesenchymal transition and migration of triple-negative breast cancer cells by inhibiting YAP/TAZ activity.
    Cao D; Zhu GY; Lu Y; Yang A; Chen D; Huang HJ; Peng SX; Chen LW; Li YW
    Biomed Pharmacother; 2020 Sep; 129():110462. PubMed ID: 32768952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer.
    Song H; Wu T; Xie D; Li D; Hua K; Hu J; Fang L
    Cell Physiol Biochem; 2018; 48(5):1968-1982. PubMed ID: 30092563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propolin G-Suppressed Epithelial-to-Mesenchymal Transition in Triple-Negative Breast Cancer Cells via Glycogen Synthase Kinase 3β-Mediated Snail and HDAC6-Regulated Vimentin Degradation.
    Pai JT; Chen XH; Leu YL; Weng MS
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
    Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J
    Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual inhibition of Wnt and Yes-associated protein signaling retards the growth of triple-negative breast cancer in both mesenchymal and epithelial states.
    Sulaiman A; McGarry S; Li L; Jia D; Ooi S; Addison C; Dimitroulakos J; Arnaout A; Nessim C; Yao Z; Ji G; Song H; Gadde S; Li X; Wang L
    Mol Oncol; 2018 Apr; 12(4):423-440. PubMed ID: 29316250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PKMYT1 Promotes Epithelial-Mesenchymal Transition Process in Triple-Negative Breast Cancer by Activating Notch Signaling.
    Li B; Huang L; Ruan J
    Rev Invest Clin; 2024; 76(1):45-59. PubMed ID: 38442372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression.
    Li Y; Zhao Z; Xu C; Zhou Z; Zhu Z; You T
    Cancer Lett; 2014 Dec; 355(1):130-40. PubMed ID: 25218351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SASH1 suppresses triple-negative breast cancer cell invasion through YAP-ARHGAP42-actin axis.
    Jiang K; Liu P; Xu H; Liang D; Fang K; Du S; Cheng W; Ye L; Liu T; Zhang X; Gong P; Shao S; Wang Y; Meng S
    Oncogene; 2020 Jul; 39(27):5015-5030. PubMed ID: 32523092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-EMT properties of CoQ0 attributed to PI3K/AKT/NFKB/MMP-9 signaling pathway through ROS-mediated apoptosis.
    Yang HL; Thiyagarajan V; Shen PC; Mathew DC; Lin KY; Liao JW; Hseu YC
    J Exp Clin Cancer Res; 2019 May; 38(1):186. PubMed ID: 31068208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II type 2 receptor-interacting protein 3a inhibits ovarian carcinoma metastasis via the extracellular HMGA2-mediated ERK/EMT pathway.
    Ping H; Guo L; Xi J; Wang D
    Tumour Biol; 2017 Jun; 39(6):1010428317713389. PubMed ID: 28651497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway.
    Zheng CH; Chen XM; Zhang FB; Zhao C; Tu SS
    Cell Biol Int; 2018 Sep; 42(10):1386-1394. PubMed ID: 29972256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of KIF3A inhibits triple negative breast cancer growth and metastasis by repressing Rb-E2F signaling and epithelial-mesenchymal transition.
    Wang W; Zhang R; Wang X; Wang N; Zhao J; Wei Z; Xiang F; Wang C
    Cancer Sci; 2020 Apr; 111(4):1422-1434. PubMed ID: 32011034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MAGE-A is frequently expressed in triple negative breast cancer and associated with epithelial-mesenchymal transition.
    Wang H; Sang M; Geng C; Liu F; Gu L; Shan B
    Neoplasma; 2016; 63(1):44-56. PubMed ID: 26639233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of ERRα suppresses epithelial mesenchymal transition of triple negative breast cancer cells by directly targeting fibronectin.
    Wu YM; Chen ZJ; Liu H; Wei WD; Lu LL; Yang XL; Liang WT; Liu T; Liu HL; Du J; Wang HS
    Oncotarget; 2015 Sep; 6(28):25588-601. PubMed ID: 26160845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.